Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H18O |
Molecular Weight | 154.2493 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)=CCC[C@@](C)(O)C=C
InChI
InChIKey=CDOSHBSSFJOMGT-JTQLQIEISA-N
InChI=1S/C10H18O/c1-5-10(4,11)8-6-7-9(2)3/h5,7,11H,1,6,8H2,2-4H3/t10-/m0/s1
Molecular Formula | C10H18O |
Molecular Weight | 154.2493 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26702985Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18640207 | https://www.ncbi.nlm.nih.gov/pubmed/25637759
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26702985
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/18640207 | https://www.ncbi.nlm.nih.gov/pubmed/25637759
Linalool, (-)- is one of enantiomers of Linalool and a fragrance ingredient used in decorative cosmetics, fine fragrances, shampoos, toilet soaps and other toiletries as well as in non-cosmetic products such as household cleaners and detergents. The maximum skin level that results from the use of l-linalool in formulae that go into fine fragrances has been reported to be 0.31%, assuming use of the fragrance oil at levels up to 20% in the final product. Linalool is used by pest professionals as a flea, fruit fly, and cockroach insecticide. It can also be used a method of pest control for codling moths. Linalool creates a synergistic effect with the codling moth's pheromone called codlemone, which increases the attraction of males. Linalool can be absorbed by inhalation of its aerosol and by oral intake or skin absorption, potentially causing irritation, pain and allergic reactions.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL3986 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22461383 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26702985
A dermal 90-day subchronic toxicity study conducted in rats determined the NOAEL to be 250 mg/kg/day
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25637759
A series of in vitro human skin penetration studieswere conducted with 4% linalool under in-use (unoccluded) and occluded conditions in diethyl phthalate (DEP), dipropylene glycol (DPG), ethanol/water, petrolatum, ethanol/DEP or ethanol/DPG vehicles.Twelve active dosed diffusion cells were prepared from seven donors for each application condition (unoccluded, occluded, and an unoccluded control cell). Epidermalmembranes were used, and their integrity was assessed by measuring the permeation rate of tritiated water over a period of 1 h. Permeation of linalool froma 5 μl/cm2 dosewas then measured at 12 time-points over 24 h. Occluded conditions reduced the loss of volatile application vehicles and test compounds but may have also increased skin hydration, factors which caused a significant increase in the permeation of linalool. Under unoccluded experimental conditions, there was a gradual but comprehensive evaporative loss. Total absorbed dose values from an unoccluded application ranged from 1.8% to 3.57% (DPG < ethanol/ DPG < ethanol/DEP < DEP < petrolatum < ethanol/water). Total absorbed dose values from an occluded application ranged from 5.73% to 14.4% (DEP < ethanol/DEP < DPG < petrolatum < ethanol/DPG < ethanol/ water). Conservatively, 14.4% dermal absorption was selected for this safety assessment.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:34:37 GMT 2023
by
admin
on
Fri Dec 15 17:34:37 GMT 2023
|
Record UNII |
3U21E3V8I2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
126-91-0
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
m6820
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | Merck Index | ||
|
204-811-2
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
3U21E3V8I2
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
DTXSID40872607
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
28
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
443158
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
3U21E3V8I2
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
1800669
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY | |||
|
100000162750
Created by
admin on Fri Dec 15 17:34:37 GMT 2023 , Edited by admin on Fri Dec 15 17:34:37 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
ASSAY (GC)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
ASSAY (GC)
|